
The $2.4B Oral Macrocycle and Bispecific Surge: Why Big Pharma Is Buying Platform Engines Over Single Assets
Dr. Dereck Mush, MD, MBAOffers bioinformatics analysis software for cell and gene therapy design.
The company provides a cloud-native platform for sequence design, data management, and machine learning modeling for gene therapies. Customers include academic research laboratories and commercial biotechnology developers.
Leadership as of 14 November 2026.
President & CEO

Dr. Dereck Mush, MD, MBARelated companies
Your daily HealthTech Signal
Get the latest HealthTech news, understand why it matters, and see where the industry is headed.



Read by teams at companies like: